Investment Summary |
|
|---|---|
| Date | 2019-10-08 |
| Target | vivitide |
| Sector | Life Science |
| Investor(s) | Ampersand Capital Partners |
| Sellers(s) | Wheelock Partners |
| Deal Type | Secondary Buyout |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 51 of 86 |
| Sector: Life Science M&A | 22 of 43 |
| Type: Secondary Buyout M&A Deals | 2 of 8 |
| State: Massachusetts M&A | 12 of 16 |
| Country: United States M&A | 48 of 70 |
| Year: 2019 M&A | 4 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-06-18 |
N2 Biomedical
Bedford, Massachusetts, United States N2 Biomedical provides coating and surface treatment development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular, and other healthcare end-markets. N2 Biomedical was founded in 2013 and is based in Bedford, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-10-29 |
Arranta Bio
Watertown, Massachusetts, United States Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. Arranta Bio was founded in 2019 and is based in Watertown, Massachusetts. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| Size | Small |
| Type | Sector Agnostic |
Wheelock Partners LLC is a private investment firm focused on acquisitions of small, profitable, New England headquartered companies. Wheelock seeks businesses with annual sales of $5 to $50 million and at least $500k of EBITDA. Prospective companies also generally have defensible market positions, diverse base of customers, and operate in niches with significant barriers to entry. Industries of interest include business services, energy services, enterprise software, financial services, industrial products, test/measurement equipment, technology, manufacturing, defense, and chemicals. Wheelock will not invest in start-ups, turnarounds, or businesses with high seasonality or cyclicality. Wheelock Partners was formed in 2004 and is based in Gardner, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Secondary Buyout M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-03-06 |
vivitide
Gardner, Massachusetts, United States vivitide is a provider of custom peptide synthesis services, custom antibodies, catalog peptides, and biochemicals to academia, pharmaceutical, biotech, and diagnostic companies worldwide. vivitide was founded in 1998 and is based in Gardner, Massachusetts. |
Buy | - |
